ARDT Stock: Price, Earnings History and SEC Filings
Ardent Health, Inc. (ARDT) last traded at $12.03, down 2.20% on the latest session and up 16.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.12 against an analyst estimate of $0.17, a miss of 29.4%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ARDT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.12 | $0.17 | -29.41% |
| Mar 2026 | May 5, 2026 | $0.28 | $0.18 | +55.56% |
| Dec 2025 | Mar 4, 2026 | $0.32 | $0.35 | -8.57% |
| Sep 2025 | Nov 12, 2025 | $0.52 | $0.42 | +23.81% |
ARDT beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How ARDT reacts to earnings
Across its last 8 earnings releases, ARDT moved 10.4% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-04 | After close | +3.81% |
| 2026-05-05 | After close | -7.50% |
| 2026-03-04 | After close | -2.07% |
| 2025-11-12 | After close | -33.81% |
| 2025-08-05 | After close | +6.10% |
| 2025-05-06 | After close | +9.22% |
| 2025-02-26 | After close | +8.21% |
| 2025-01-13 | After close | -12.46% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ARDT financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $6.3B | $136M | – | 2.1% | $0.96 |
| 2024 | $6.0B | $210M | – | 3.5% | $1.58 |
| 2023 | $5.4B | $54M | – | 1.0% | $0.43 |
| 2022 | $5.1B | $189M | – | 3.7% | $1.50 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ARDT
- 8-K · Oct 23, 2026Officer or director change
- 8-K · Sep 4, 2026Other events, Financial statements and exhibits
- 10-Q · Aug 10, 2026
- 8-K · Aug 4, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 30, 2026Officer or director change, Financial statements and exhibits
- 8-K · Jun 2, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 26, 2026Shareholder vote
- 10-Q · May 6, 2026
- 8-K · May 5, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 8, 2026
Insider filing activity
ARDT insiders filed 3 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ARDT news
- Ardent Health (ARDT) Stock Looks Like A Bargain As It Gains 43% YTDOct 23, 2026 · finance.yahoo.com
- How New Digital Chief Will Impact Ardent Health (ARDT) StockOct 22, 2026 · finance.yahoo.com
- Ardent Health Appoints Gaurav Khanna as Chief Digital & Information OfficerOct 21, 2026 · finance.yahoo.com
About Ardent Health, Inc.
Ardent Health, Inc. (ARDT) is a US-listed public company on NYSE. The SEC classifies its business as Services-general Medical & Surgical Hospitals NEC. It is incorporated in DE. Its fiscal year ends in December.